性饮食对人类胰岛素样生长因子 (IGF) -1 的影响:系统性审查和元分析
Gayathiri Rajakumar1, Maria Lastra Cagigas1, Tian Wang2
1Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia; Sydney Medical School, Nepean Clinical School, Faculty of Medicine and Health, University of Sydney, Kingswood, NSW 2747, Australia.
Ageing research reviews
|October 13, 2024
概括
在成年人中,ad libitum食 (KDs) 显著降低了胰岛素样生长因子 (IGF) -1 血清水平. 这种饮食方法可以降低IGF-1,而不需要禁食或严重的卡路里限制,为衰老和癌症研究提供潜在的好处.
科学领域:
- 代谢健康 代谢健康
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 胰岛素类生长因子 (IGF-1) 与衰老和癌症有关.
- 已知禁食会降低血清IGF-1,但自发食 (KDs) 的效果尚不清楚.
研究的目的:
- 进行对任意食 (KDs) 对成年人血清IGF-1水平的影响的元分析.
主要方法:
- 在2023年6月之前对Ovid,PubMed,Scopus和CENTRAL数据库进行系统的文献搜索.
- 对人体试验的分析,在这些试验中,KDs被处方,症被证实,IGF-1被测量.
- 排除涉及规定禁食或能量限制的研究.
主要成果:
- 十项涉及236名参与者的试验显示,KD干预后血清IGF-1显著降低 (MD: -24.9 ng/mL).
- 性饮食也与禁食胰岛素和葡萄糖的显著下降有关.
- 亚组分析没有发现基于研究设计,性别,持续时间或瘤状况的显著差异.
结论:
- 适应性类饮食有效地将血清IGF-1降低约20%,同时降低了禁食葡萄糖和胰岛素.
- 这些减少可以在没有规定禁食或严重的卡路里限制的情况下实现.
- 需要进一步研究KDs对衰老生物标志物和癌症管理的影响.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Insulin: Dosing Regimen and Adverse Effects
152
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
152
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Hypoglycemia and Glucagon
164
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
164


